Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats
2016 · Toxicology Mechanisms and Methods · 50 citations
https://doi.org/10.1080/15376516.2016.1236425
M
Mohammad M. Al-Harbi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
1.1K
Citations
17
h-index
20
i10-index
Mohammad M. Al-Harbi is an academic researcher from National Guard Health Affairs. The author has contributed to research in topics: Asthma and respiratory diseases & Immune Response and Inflammation & Acute Kidney Injury Research. The author has an h-index of 17, co-authored 29 publications.
Papers by this author
worksEffect of Apremilast on LPS-induced immunomodulation and inflammation via activation of Nrf2/HO-1 pathways in rat lungs
2023 · Saudi Pharmaceutical Journal · 9 citations
https://doi.org/10.1016/j.jsps.2023.05.022
Protective effect of Apremilast against LPS-induced acute lung injury via modulation of oxidative stress and inflammation
2022 · Saudi Journal of Biological Sciences · 7 citations
https://doi.org/10.1016/j.sjbs.2022.02.023
Optimal approaches for managing recurrent macular holes: a comprehensive systematic review and meta-analysis
2025 · Graefe s Archive for Clinical and Experimental Ophthalmology · 0 citations
https://doi.org/10.1007/s00417-025-06981-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat